The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer.

Pierfrancesco FrancoFrancesco MontagnaniFrancesca ArcadipaneChiara CasadeiKalliopi AndrikouStefania MartiniGiuseppe Carlo IorioMario ScartozziMassimiliano MistrangeloLorenzo FornaroPaola CassoniStefano CascinuUmberto RicardiAndrea Casadei Gardini

Published in: Radiation oncology (London, England) (2018)

We showed that baseline Hb level is a strong indicator for poor response to RT-CT in anal cancer patients. A close clinical monitoring for incomplete response to treatment should be advised in patients with low pre-treatment Hb. The hypothesis that the preservation of adequate Hb level during treatment may lead to a better outcome needs prospective evaluation.

Keyphrases

patients undergoing
computed tomography
combination therapy
papillary thyroid
squamous cell carcinoma
photodynamic therapy
locally advanced
young adults
radiation therapy
magnetic resonance
contrast enhanced
replacement therapy
radiation induced
pet ct